New Delhi [India], February 3 (ANI/NewsVoir): In recent years, an increasing number of Indians have given up their citizenship. Government officials said over 100,000 Indians surrendered their citizenship in the first nine months of 2021, and more than 600,000 Indians renounced their citizen
New Delhi [India], February 3 (ANI/PNN): The Nationwide Awards Under 40 Industry Experts - 2022 aims to recognize organizations and pioneers who have led change in specific industry verticals and fields of business by using innovation to better business performance.
Islamabad [Pakistan], February 2 (ANI): Pakistan Prime Minister Imran Khan has received heavy criticism from experts for travelling around the world with a "begging bowl" seeking financial support as people in his country continue to suffer from inflation and price rise.
Washington [US], February 2 (ANI): Bob Wall, the martial arts expert, actor and stuntman who fought with Bruce Lee in 'The Way of the Dragon', 'Enter the Dragon' and 'Game of Death', has died at the age of 82.
New Delhi [India], February 2 (ANI): Highlighting the role of the real estate sector in India's economy, industry experts termed the Union Budget 2022-23 as a growth-inducing budget.
New Delhi [India], February 1 (ANI): Welcoming the Union Budget for FY 2022-23, industry experts said the government's renewed focus on healthcare will build stronger health systems in the country.
Tel Aviv [Israel], February 1 (ANI): The Pashtun nationalism across Durand Line is problematic for Pakistan as it focuses on loyalty to the clan rather than the country.
New Delhi [India], January 31 (ANI): A professionally determined valuation of jewellery can be useful for insurance, foreign travel, family settlement and for wealth tax or sale purposes, experts have said.
New Delhi [India], January 30 (ANI): After the country achieved the milestone of vaccinating 75 per cent of the country's adult population against COVID-19, MD of Lok Nayak Jai Prakash Narayan Hospital (LNJP) Dr Suresh Kumar on Sunday said that the country's COVID-19 vaccination programme
New Delhi [India], January 30 (ANI): As Hyderabad-based drug maker Bharat Biotech has got regulatory approval to conduct Phase-3 clinical trials of its intranasal COVID-19 vaccine as a booster dose, senior epidemiologist in All India Institute of Medical Sciences (AIIMS) in Delhi, Dr Sanjay